Relationship of natalizumab exposure and MRI response in patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

被引：0
|
作者：
Muralidharan, K. Kandadi [1 ]
Steiner, D. [1 ]
Elkins, J. [1 ]
Ho, P. -R. [1 ]
Amarante, D. [1 ]
Koendgen, H. [1 ]
Evans, K. [1 ]
Mikol, D. [1 ]
机构：
[1] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1554
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [21] Perspective taking deficits and their relationship with theory of mind abilities in patients with relapsing-remitting multiple sclerosis (RRMS)
    Bruno, Diana
    Galiani, Agostina
    Golfeder, Maria
    Cassara, Fatima Pagani
    Duncan, John
    Sinay, Vladimiro
    Roca, Maria
    APPLIED NEUROPSYCHOLOGY-ADULT, 2022,
  • [22] Relationship between MRI lesion activity and response to IFN-β in relapsing-remitting multiple sclerosis patients
    Rio, J.
    Rovira, A.
    Tintore, M.
    Huerga, E.
    Nos, C.
    Tellez, N.
    Tur, C.
    Comabella, M.
    Montalban, X.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (04) : 479 - 484
  • [23] Natalizumab: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2014, 30 (2) : 48 - 54
  • [24] Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis
    Meuth, Sven G.
    Bittner, Stefan
    Seiler, Carola
    Goebel, Kerstin
    Wiendl, Heinz
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (02) : 198 - 203
  • [25] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [26] COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN RUSSIA
    Matveev, N., V
    Sabanov, A., V
    Luneva, A., V
    VALUE IN HEALTH, 2014, 17 (03) : A60 - A60
  • [27] Monitoring cognition in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients
    White, J.
    Gabriele, S.
    Lin, D.
    Vindici, J.
    Teoh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 214 - 214
  • [28] Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis
    Bittner, S.
    Meuth, S.
    Seiler, C.
    Reiners, K.
    Wiendl, H.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S247 - S247
  • [29] Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS)
    Mashayekhi, Farhad
    Hadipour, Elham
    Shabani, Somayeh
    Salehi, Zivar
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 237
  • [30] Depression in early relapsing-remitting Multiple Sclerosis (RRMS) patients with higher risk of progression
    Cihelkova, S.
    Baranikova, Z.
    Jung, M.
    Bojar, M.
    JOURNAL OF NEUROLOGY, 2010, 257 : S189 - S190
12345